March 10, 2026

Arcutis Biotherapeutics (ARQT): Investor Outlook with a Promising 40% Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is making waves in the biotech sector with its innovative approach to dermatological treatments. As a company focused on developing and..

Innoviva, Inc. (INVA) Stock Analysis: A 48.75% Upside Potential in the Healthcare Sector

Innoviva, Inc. (NASDAQ: INVA) is capturing the attention of savvy investors with its notable 48.75% potential upside, presenting an intriguing opportunity in the healthcare sector. As..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a Biotech Investment with Over 100% Potential Upside

Biohaven Ltd. (BHVN), a pioneering biopharmaceutical company, is making waves in the healthcare sector with its robust pipeline aimed at tackling some of the most challenging..

SS Innovations International (SSII) Growth Potential: Riding a 192.5% Revenue Surge in the Medical Devices Sector

SS Innovations International Inc. (SSII), a dynamic player in the healthcare sector, is making waves within the medical devices industry. Headquartered in Gurugram, India, this commercial-stage..

AdaptHealth Corp. (AHCO) Stock Analysis: Unveiling a 33% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors seeking to capitalize..

CONMED Corporation (CNMD) Stock Analysis: Potential 20% Upside Beckons Investors

Investors eyeing the healthcare sector may want to take a closer look at CONMED Corporation (NASDAQ: CNMD), a key player in the medical devices industry. Headquartered..

Arrowhead Pharmaceuticals, Inc. (ARWR)

⚠️ No article content returned.

..

QuidelOrtho Corporation (QDEL) Stock Analysis: 74.56% Potential Upside Sparks Investor Interest

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector specializing in medical devices, has caught the attention of investors with its significant potential upside..

Galapagos NV (GLPG) Stock Analysis: Revenue Growth Soars Despite a Challenging Landscape

Galapagos NV (NASDAQ: GLPG), the Belgium-based biotechnology firm, has captured investor attention with its impressive revenue growth of 1,093.20%. As a specialist in oncology and immunology,..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 44% Potential Upside in Gene Editing Revolution

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering biotechnology company, stands at the forefront of the healthcare sector with its innovative CRISPR/Cas9 gene-editing platform. Headquartered in Zug,..

Astrana Health Inc. (ASTH) Investor Outlook: Analyst Ratings Suggest a 45% Upside Potential

Astrana Health Inc. (ASTH), a key player in the U.S. healthcare sector, is capturing investor attention with its promising growth potential and analyst ratings indicating a..

Xenon Pharmaceuticals Inc. (XENE) Stock Report: Exploring a Promising 18.67% Potential Upside

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology powerhouse specializing in neuroscience therapeutics, has rapidly ascended as a compelling investment opportunity within the healthcare sector. With..

Recursion Pharmaceuticals (RXRX) Stock Analysis: Exploring a 91% Potential Upside in Biotechnology

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology sector with its innovative approach to drug discovery, leveraging cutting-edge technology to decode biology and..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Healthcare Player with a 1.59% Dividend Yield

National HealthCare Corporation (NHC), a stalwart in the healthcare sector, offers investors a robust business model centered around medical care facilities. With a market capitalization of..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Exploring a Potential 39% Upside in the Booming Biotechnology Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is making waves in the biotechnology sector with its innovative approach to immune medicine. As a commercial-stage company, Adaptive Biotechnologies has..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a Potential 67% Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find Azenta, Inc. (NASDAQ: AZTA) an intriguing prospect, especially given its potential upside of 67.17% based on the..

Neogen Corporation (NEOG) Stock Analysis: A 20% Upside Potential Despite Revenue Challenges

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a unique opportunity for investors. With a market..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem with 57.30% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a promising player in the biotechnology sector, stands at the forefront of developing innovative therapies for cardiometabolic diseases. As a..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a Potential 44% Upside

Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, is capturing investor attention with a notable potential upside of 44.19% based on..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Evaluating a 34% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD) is a prominent player in the healthcare sector, focusing on medical care facilities across the United States. With a market..

Search

Funds

March 10, 2026

Search

Funds

March 10, 2026

FTSE 100

Funds